Development of 3-in-1 nanotherapeutic strategies for ovarian cancer
E. Durocher, S. McGrath, E. Gahunia, N. Matsuura, S. Gadde
This paper develops a 3-in-1 nanotherapeutic approach combining cisplatin, olaparib, and metformin for ovarian cancer, showing stability and enhanced therapeutic effects in vitro.
bioRxiv · Jul 17, 2024 · PreprintBioengineering